Temozolomide 5 Mg Capsule Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets and Oral Capsules
Available Strengths: Capsules: 5 mg, 20 mg, 100 mg, 140 mg; Tablets: 250 mg
Reference Brands: Temodar® (US & EU)
Category: Oncology Cancer Care
Temozolomide (brand name Temodar®) is an oral chemotherapy used for glioblastoma multiforme (GBM) and anaplastic astrocytoma. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is approved in both the US and EU. Manufactured under GMP standards, Temozolomide is a key oncology treatment for global B2B pharmaceutical distribution.
Product Description:
Temozolomide is an oral chemotherapy agent used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, two aggressive brain cancers. Temozolomide works by damaging cancer cell DNA, preventing replication and inducing cell death. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is marketed under the brand name Temodar® by Merck in both the US and EU. Manufactured under GMP-compliant facilities, it offers a reliable treatment option for oncology-focused pharmaceutical partners, providing a vital oral chemotherapy solution in the global cancer treatment market.
Temozolomide 5 Mg Capsule — third party manufacturing & bulk supply
Temozolomide 5 Mg Capsule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Temozolomide 5 Mg Capsule is supplied as Oral Tablets and Oral Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Temozolomide 5 Mg Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Temozolomide 5 Mg Capsule →Frequently Asked Questions
Temozolomide is an antineoplastic (anti-cancer) medicine used primarily for the treatment of certain brain cancers, including glioblastoma multiforme and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, which inhibits their ability to multiply and causes cell death. Temozolomide is often used in combination with radiotherapy or as maintenance therapy to improve treatment outcomes.
Temozolomide is made from the active pharmaceutical ingredient temozolomide, an oral alkylating agent that belongs to the imidazotetrazine class of chemotherapeutic drugs.
The main trade name is Temodar. Other regional brand names include Temodal and Temcad.
Temodar was originally developed and marketed by Merck & Co. Generic versions are manufactured by various pharmaceutical companies worldwide.
The generic name is temozolomide.
Brand names include Temodar, Temodal, and Temcad, along with multiple regional generics.
Temozolomide is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.
Related Products
Teniposide
Strength:
50 mg/5 mL (10 mg/mL vial)
Form: Injection (IV)
Reference Brands: Vumon® (EU & US)
View Details
Ixazomib
Strength:
2.3 mg, 3 mg, 4 mg
Form: Capsules
Reference Brands: Ninlaro® (EU & US)
View Details
Tamoxifen Tablet
Strength:
10 mg, 20 mg, 40 mg
Form: Tablet
Reference Brands: Nolvadex (USA)
View Details
Lapatinib 250 Mg Tablet
Strength:
250 mg
Form: Tablets
Reference Brands: Herduo (India), Tykerb (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
